Key result
Acute ischaemic stroke is linked to reduced marginal zone-like B cells, driven by elevated noradrenaline.
Why the study?
Does acute ischaemic stroke alter the composition and function of circulating B cells?
Observational
Does acute ischaemic stroke alter the composition and function of circulating B cells?
Acute ischaemic stroke induces rapid systemic immune dysfunction characterized by the loss and altered functionality of innate-like marginal zone B cells, potentially mediated by neuroimmune factors like noradrenaline.
• Acutely after stroke, circulating MZ-like B cells (an important source of early pathogen protective IgM) are substantially reduced in frequency, in comparison to non-stroke controls. • B cells show altered innate-like functionality, with reduced capacity to upregulate immunoglobulin M and cytokine production in response to bacterial-type (TLR9) stimulation. • MZ-like B cells are sensitive to noradrenaline signalling, and exposure of healthy B cells to noradrenaline ex vivo recapitulates cellular loss observed in stroke patients. • Lower MZ-like B cell frequencies are associated with stroke but not impacted by infection. Distinct B cell populations are found in circulation, including those with innate-like properties, that have varied functions in pathogen protection, vaccination and immunoregulation. The effects of tissue injury on circulating B cell populations are poorly explored. Here we show that, following acute ischaemic stroke (AIS), a common cause of neurological disability associated with systemic immune dysfunction, the circulating B cell compartment has altered functionality, alongside marked reductions in marginal zone (MZ)-like B cells, an innate-like B cell subset. Of note, release of Immunoglobulin (Ig) M, a key innate-like B cell-derived factor important in anti-bacterial responses, and regulatory cytokines including IL-6 and IL-10, was impaired upon stimulation of sorted B cells from AIS patients. B cells express adrenergic receptors, in both control and AIS patients, and release of the β2-AR agonist noradrenaline (NA) is elevated acutely following stroke. In vitro exposure of B cells from healthy individuals to NA recapitulated some of the functional modulation observed in AIS patients. Moreover, increased cell death of MZ-like B cells was observed in response to NA. Secondary infection is a common post-stroke complication that could be responsible for altered B cell characteristics. However, in line with the impact of NA on B cell populations, alterations were largely driven by stroke rather than secondary infection. Taken together, these findings demonstrate that neuroimmune factors are an important signal that could rapidly modify defined B cell populations early after tissue injury and highlight altered innate-like B cell function as a previously unappreciated characteristic of the systemic immunological response to acute stroke.
No takes yet. Share an insight, caveat, or question.
Younas et al. (2025) conducted an observational in Acute ischaemic stroke. Acute ischaemic stroke vs. Non-stroke controls was evaluated on Frequency and functionality of circulating marginal zone (MZ)-like B cells. Acute ischaemic stroke is associated with a marked reduction in marginal zone-like B cells and impaired innate-like B cell functionality, likely driven by elevated noradrenaline signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: